Nestmedic (WAR:NST) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


WAR:NST Nestmedic SA WAR:NST
40 GF Score
Price zł0.65
GF Value zł0.42
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nestmedic Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Nestmedic's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

WAR:NST vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Nestmedic's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nestmedic Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nestmedic's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Nestmedic's Margin of Safety % (DCF Earnings Based) falls into.


WAR:NST
40GF Score
Nestmedic SA WAR:NST
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nestmedic (WAR:NST) Overvalued in 2026?

Based on GuruFocus' analysis, Nestmedic stock appears to be overvalued. The current stock price of zł0.65 is trading 54.8% above its estimated GF Value™ of zł0.42. GuruFocus considers Nestmedic to be Significantly Overvalued.

Key valuation signals for WAR:NST:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: zł0.42 vs. price of zł0.65 (54.8% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the WAR:NST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nestmedic Business Description

Address ul. Pasymska 20, Warszawa, POL, 01-993
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
40GF Score

Get the complete analysis for WAR:NST

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.65
Price
zł0.42
GF Value